Steven N. Quayle
Steven N. Quayle publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors and CAR-T cell therapy research.
- World rank
- #889,156 of 7,710,434 ranked researchers
- Rank in United States
- #293,725 of 1,627,098
- Works
- 123
- Citations
- 2.4k
- Citations per work
- 19.4
What does Steven N. Quayle research?
Steven N. Quayle's work is mostly in Biochemistry, Genetics and Molecular Biology (50%), Medicine (23%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences7258.3%
- Health Sciences2923.3%
- Medicine2923.3%
- Everything else2318.4%
- 1Molecular Biology46% of their works
- 2Oncology14% of their works
- 3Immunology8% of their works
- 4Hematology6% of their works
- 5Genetics4% of their works
- 6Genetics3% of their works
Research topics
Which keywords describe Steven N. Quayle's research?
The keywords of their largest research topics: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, BET Bromodomains, PROTACs, Cancer Immunotherapy, CAR T Cells and Chimeric Antigen Receptor.
- Immunity
- Histone Modification
- Viral Vectors
- International Myeloma Working Group
- Tumor Microenvironment
- Chimeric Antigen Receptor
- Cancer Immunotherapy
- BET Bromodomains
- HDAC Inhibitors
- Cancer Therapy
- Histone Deacetylases
- PROTACs
- CAR T Cells
- Fibroblast Activation Protein
- Diagnosis Criteria
- Gene Therapy
- DNA Methylation
- Dendritic Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cancer Therapy502 topics
- HDAC Inhibitors411 topic
- Histone Deacetylases411 topic
- BET Bromodomains261 topic
- PROTACs261 topic
- Cancer Immunotherapy152 topics
- CAR T Cells101 topic
- Chimeric Antigen Receptor101 topic
- Fibroblast Activation Protein91 topic
- Tumor Microenvironment91 topic
- Diagnosis Criteria81 topic
- International Myeloma Working Group81 topic
- Gene Therapy71 topic
- Viral Vectors71 topic
- DNA Methylation61 topic
- Histone Modification61 topic
- Dendritic Cells51 topic
- Immunity51 topic
Where does Steven N. Quayle work?
Steven N. Quayle's main affiliation in the publication record is Acetylon Pharmaceuticals (United States), United States.
How many publications and citations does Steven N. Quayle have?
OpenAlex counts 123 works and 2,389 citations for Steven N. Quayle, an h-index of 21, ranking #889,156 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Steven N. Quayle. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.